Vir Biotechnology, Inc.
VIR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $1 | $3 | $12 |
| % Growth | -80.2% | -60% | -75.5% | – |
| Cost of Goods Sold | $151 | $98 | $118 | $89 |
| Gross Profit | -$151 | -$96 | -$115 | -$76 |
| % Margin | -63,005% | -7,932.9% | -3,779.1% | -617.5% |
| R&D Expenses | $151 | $98 | $119 | $106 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $22 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$151 | -$75 | -$94 | -$65 |
| Operating Expenses | $22 | $22 | $25 | $41 |
| Operating Income | -$173 | -$118 | -$140 | -$117 |
| % Margin | -72,267.9% | -9,754.3% | -4,602.5% | -946.7% |
| Other Income/Exp. Net | $10 | $8 | $19 | $12 |
| Pre-Tax Income | -$163 | -$111 | -$121 | -$105 |
| Tax Expense | $0 | $0 | $0 | -$0 |
| Net Income | -$163 | -$111 | -$121 | -$105 |
| % Margin | -67,975.4% | -9,139.9% | -3,989.6% | -845.2% |
| EPS | -1.17 | -0.8 | -0.88 | -0.76 |
| % Growth | -46.2% | 9.1% | -15.8% | – |
| EPS Diluted | -1.17 | -0.8 | -0.88 | -0.76 |
| Weighted Avg Shares Out | 139 | 138 | 137 | 137 |
| Weighted Avg Shares Out Dil | 139 | 138 | 137 | 137 |
| Supplemental Information | – | – | – | – |
| Interest Income | $9 | $11 | $12 | $14 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $3 | $3 | $3 | $3 |
| EBITDA | -$160 | -$116 | -$136 | -$100 |
| % Margin | -66,656.3% | -9,528.2% | -4,474.3% | -810% |